Jpmorgan Chase & CO Htg Molecular Diagnostics, Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.62 - $1.89 $223 - $682
-361 Reduced 93.28%
26 $0
Q2 2022

Aug 11, 2022
BUY
$0.46 - $1.45 $23 - $72
50 Added 14.84%
387 $0
Q1 2022

May 11, 2022
BUY
$1.39 - $5.51 $430 - $1,708
310 Added 1148.15%
337 $0
Q4 2021

Feb 10, 2022
BUY
$3.23 - $5.97 $87 - $161
27 New
27 $0

Others Institutions Holding HTGM

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About HTG MOLECULAR DIAGNOSTICS, INC

HTGM Quotes by TradingView
  • Ticker HTGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 11,048,100
  • Market Cap $3.76M
  • Description
  • HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...
More about HTGM
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email